BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15765122)

  • 1. Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.
    Matsuda M; Nakamoto Y; Suzuki S; Kurata T; Kaneko S
    Lab Invest; 2005 May; 85(5):655-63. PubMed ID: 15765122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
    Shibata Y; Hara T; Nagano J; Nakamura N; Ohno T; Ninomiya S; Ito H; Tanaka T; Saito K; Seishima M; Shimizu M; Moriwaki H; Tsurumi H
    PLoS One; 2016; 11(1):e0146279. PubMed ID: 26727596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
    Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
    Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
    Kinoshita A; Wanibuchi H; Morimura K; Wei M; Shen J; Imaoka S; Funae Y; Fukushima S
    Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
    Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
    Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide deficiency attenuates promotion of hepatocarcinogenesis by cytotoxicity in NADPH oxidase knockout mice.
    Parzefall W; Freiler C; Lorenz O; Koudelka H; Riegler T; Nejabat M; Kainzbauer E; Grasl-Kraupp B; Schulte-Hermann R
    Arch Toxicol; 2015 Aug; 89(8):1383-93. PubMed ID: 25182417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.
    Shirakami Y; Gottesman ME; Blaner WS
    Carcinogenesis; 2012 Feb; 33(2):268-74. PubMed ID: 22116467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo.
    Kang JS; Wanibuchi H; Morimura K; Gonzalez FJ; Fukushima S
    Cancer Res; 2007 Dec; 67(23):11141-6. PubMed ID: 18056438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
    Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
    Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rac1 promotes diethylnitrosamine (DEN)-induced formation of liver tumors.
    Bopp A; Wartlick F; Henninger C; Schwarz M; Kaina B; Fritz G
    Carcinogenesis; 2015 Mar; 36(3):378-89. PubMed ID: 25556150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor promotion in liver of mice with a conditional Cx26 knockout.
    Marx-Stoelting P; Mahr J; Knorpp T; Schreiber S; Templin MF; Ott T; Buchmann A; Schwarz M
    Toxicol Sci; 2008 Jun; 103(2):260-7. PubMed ID: 18308698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
    Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
    Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17A Plays a Pivotal Role in Chemically Induced Hepatocellular Carcinoma in Mice.
    Sun C; Kono H; Furuya S; Hara M; Hirayama K; Akazawa Y; Nakata Y; Fujii H
    Dig Dis Sci; 2016 Feb; 61(2):474-88. PubMed ID: 26467699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
    Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor effect of pegylated interferon in the rat hepatocarcinogenesis model.
    Miki A; Yano Y; Kato H; Seo Y; Kuriyama M; Azuma T; Hayashi Y
    Int J Oncol; 2008 Mar; 32(3):603-8. PubMed ID: 18292937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking the IFN-gamma receptor or fyn develop severe experimental autoimmune uveoretinitis characterized by different immune responses.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Udaka K; Ueno H
    Immunogenetics; 2005 Jun; 57(5):337-43. PubMed ID: 15902435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular ATP and Purinergic P2Y
    Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
    Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.